Journal of Cancer Research and Pharmacology (eISSN: 3115-798X) (J Cancer Res Pharmacol) conforms to the international regulations against scientific misconduct including fabrication, falsification, plagiarism, etc. J Cancer Res Pharmacol adheres to Committee on Publication Ethics (COPE) and any cases of suspected misconduct (such as redundant publication) will be assessed during the peer-review and publication process based on COPE guidelines. In addition, all pre or post-publication issues will be managed based on COPE’s code of conduct and flowcharts.